3 top ASX growth shares I'd buy next week

Xero is one of the ASX growth shares that I think looks good value today.

| More on:
Four piles of coins, each getting higher, with trees on them.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • These three ASX growth shares look good value to me after heavy falls in 2022
  • Xero is one of those businesses, with ongoing global growth and a rising gross profit margin
  • Australian Ethical is another business that is achieving long-term growth and looks more attractively valued after a 60% fall in 2022

I think some ASX growth shares are now looking very attractive after the volatility we've seen this year.

Lower prices could mean better value for businesses that have growth planned for the long-term.

These three potential investments look like attractive propositions to me:

Xero Limited (ASX: XRO)

Xero is one of the largest ASX tech shares, I also think it's one of the highest quality businesses.

It has an exceptionally high gross profit margin. In the FY22 result, its gross margin was 87.3%, an increase from 86% in FY21.

The company is achieving global growth and it can use the rapidly-growing gross profit to invest in areas, like marketing and subscriber tools, which can lead to more growth. FY22 operating revenue increased 29% to almost NZ$1.1 billion and subscribers rose 19% to 3.27 million.

While some investors may prefer that Xero generate more profit in the shorter term, I like that Xero said it will "continue to focus on growing its global small business platform and maintain a preference for reinvesting cash generated…to drive long-term shareholder value".

Despite a 9% jump in the Xero share price on Friday, the ASX growth share is still down more than 40% this year, so it seems quite a bit cheaper.

Betashares Global Quality Leaders ETF (ASX: QLTY)

As the name implies, I think this exchange-traded fund (ETF) could be a quality idea.

There are four metrics that a company needs to rank well on to be potentially selected for this portfolio: a high return on equity and profitability, low amounts of debt, and earnings stability.

There are around 150 names in the global portfolio. The biggest weighting is 2.3%, so no business has a large position – there is diversification.

Some of the names in the portfolio include Johnson & Johnson, Pfizer, Meta Platforms, Novo Nordisk, Unitedhealth, Visa, AIA, Texas Instruments, Accenture, and Adobe.

The annual management fee of the ETF is 0.35%. This is relatively low compared to plenty of active fund managers that may charge 1% or more.

The QLTY ETF has seen a decline of around 20% since the beginning of the year, despite those quality metrics.

Australian Ethical Investment Limited (ASX: AEF)

Australian Ethical is a fund manager that wants to provide investors with investment products that align with their ethics.

The ASX growth share avoids areas such as tobacco, coal miners, and gas. Instead, Australian Ethical invests in businesses that are connected by its conviction that "their success is linked to society's prosperity and the planet's wellbeing".

It is certainly true that the current market volatility is not helpful for the short-term direction of the company's funds under management (FUM).

However, its FUM does continue to grow on longer-term time scales. Since the start of FY22, FUM has risen by 13% to $6.83 billion. During the three months to March 2022, the fund manager saw FUM inflows of around $0.24 billion.

Australian Ethical said that its positive net inflows for the quarter were driven by ongoing "strong" superannuation contributions. This includes the regular superannuation guarantee contributions together with rollovers from new customers joining.

Over the long-term, I think its FUM can keep growing, with a reduction of the management fees being a positive for attracting more investors.

I think the Australian Ethical share price is now more attractive after falling almost 60% since the start of 2022.

Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Adobe Inc., Australian Ethical Investment Ltd., Meta Platforms, Inc., Visa, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Johnson & Johnson and has recommended the following options: long January 2024 $420 calls on Adobe Inc. and short January 2024 $430 calls on Adobe Inc. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Adobe Inc., Australian Ethical Investment Ltd., and Meta Platforms, Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »